Literature DB >> 18359131

Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances.

Dietmar Rudolf Thal1, Estibaliz Capetillo-Zarate, Sergey Larionov, Matthias Staufenbiel, Stefan Zurbruegg, Nicolau Beckmann.   

Abstract

The role of cerebral amyloid angiopathy (CAA) in the pathogenesis of Alzheimer's disease (AD) is not fully understood. Here, we studied whether CAA is associated with alterations in microvascularisation in transgenic mouse models and in the human brain. APP23 mice at 25-26 months of age exhibited severe CAA in thalamic vessels whereas APP51/16 mice did not. Wild-type littermates were free of CAA. We found CAA-related capillary occlusion within the thalamus of APP23 mice but not in APP51/16 and wild-type mice. Magnetic resonance angiography (MRA) showed blood flow alterations in the thalamic vessels of APP23 mice. CAA-related capillary occlusion in the branches of the thalamoperforating arteries of APP23 mice, thereby, corresponded to the occurrence of blood flow disturbances. Similarly, CAA-related capillary occlusion was observed in the human occipital cortex of AD cases but less frequently in controls. These results indicate that capillary CAA can result in capillary occlusion and is associated with cerebral blood flow disturbances providing an additional mechanism for toxic effects of the amyloid beta-protein in AD.

Entities:  

Mesh:

Year:  2008        PMID: 18359131     DOI: 10.1016/j.neurobiolaging.2008.01.017

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  55 in total

1.  Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease.

Authors:  Ai-Ling Lin; Wei Zheng; Jonathan J Halloran; Raquel R Burbank; Stacy A Hussong; Matthew J Hart; Martin Javors; Yen-Yu Ian Shih; Eric Muir; Rene Solano Fonseca; Randy Strong; Arlan G Richardson; James D Lechleiter; Peter T Fox; Veronica Galvan
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-26       Impact factor: 6.200

2.  The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients.

Authors:  Karin Hultman; Sidney Strickland; Erin H Norris
Journal:  J Cereb Blood Flow Metab       Date:  2013-05-08       Impact factor: 6.200

Review 3.  Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.

Authors:  Livius V d'Uscio; Tongrong He; Zvonimir S Katusic
Journal:  Physiology (Bethesda)       Date:  2017-01

4.  Aberrant functional connectivity in Papez circuit correlates with memory performance in cognitively intact middle-aged APOE4 carriers.

Authors:  Wenjun Li; Piero G Antuono; Chunming Xie; Gang Chen; Jennifer L Jones; B Douglas Ward; Suraj P Singh; Malgorzata B Franczak; Joseph S Goveas; Shi-Jiang Li
Journal:  Cortex       Date:  2014-04-30       Impact factor: 4.027

Review 5.  The vascular contribution to Alzheimer's disease.

Authors:  Robin Altman; John C Rutledge
Journal:  Clin Sci (Lond)       Date:  2010-08-05       Impact factor: 6.124

Review 6.  Beta-amyloid, blood vessels, and brain function.

Authors:  Eric E Smith; Steven M Greenberg
Journal:  Stroke       Date:  2009-05-14       Impact factor: 7.914

Review 7.  Vascular pathology in the aged human brain.

Authors:  Lea Tenenholz Grinberg; Dietmar Rudolf Thal
Journal:  Acta Neuropathol       Date:  2010-02-14       Impact factor: 17.088

Review 8.  Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations.

Authors:  Kenzo Koizumi; Gang Wang; Laibaik Park
Journal:  Cell Mol Neurobiol       Date:  2015-09-02       Impact factor: 5.046

9.  Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease.

Authors:  Roy O Weller; Stephen D Preston; Malavika Subash; Roxana O Carare
Journal:  Alzheimers Res Ther       Date:  2009-10-12       Impact factor: 6.982

10.  Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium.

Authors:  Irina Alafuzoff; Dietmar R Thal; Thomas Arzberger; Nenad Bogdanovic; Safa Al-Sarraj; Istvan Bodi; Susan Boluda; Orso Bugiani; Charles Duyckaerts; Ellen Gelpi; Stephen Gentleman; Giorgio Giaccone; Manuel Graeber; Tibor Hortobagyi; Romana Höftberger; Paul Ince; James W Ironside; Nikolaos Kavantzas; Andrew King; Penelope Korkolopoulou; Gábor G Kovács; David Meyronet; Camelia Monoranu; Tatjana Nilsson; Piero Parchi; Efstratios Patsouris; Maria Pikkarainen; Tamas Revesz; Annemieke Rozemuller; Danielle Seilhean; Walter Schulz-Schaeffer; Nathalie Streichenberger; Stephen B Wharton; Hans Kretzschmar
Journal:  Acta Neuropathol       Date:  2009-02-01       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.